Indeed, C9Pos patients with larger expansions had a more severe cognitive impairment, thereby supporting the emerging hypothesis that C9orf72 HRE size may be a modifier factor of phenotype along the ALS-FTD clinical spectrum [30]. This evidence concerns the gene C9orf72 and Cognitive impairment.